COLUMBIA, S.C. -- Attorney General Henry McMaster announced today that consumers should be on the alert, and immediately report, suspected price gouging by either distributors or providers of the flu vaccine.
McMaster has alerted the Centers for Disease Control and Prevention (CDC) to contact his office with any complaints and inquiries about vaccine price gouging in South Carolina. The CDC is neither equipped nor empowered to take action against these alleged law violations.
"We are not presently aware of any instances of price gouging taking place in South Carolina," said McMaster. "However, due to the limited distribution of the flu vaccine this season, the opportunity is present for a distributor or provider to gouge consumers. Anyone seeking to exploit this shortage of medicine for financial gain will be prosecuted fully and aggressively, continued McMaster, who also noted that he would forego a flu shot this year.
A new survey conducted Oct. 8-13, 2004 by the American Society of Health-System Pharmacists (ASHP) reveals that some pharmaceutical distributors are actively soliciting U.S. hospitals and offering the flu vaccine at vastly inflated prices. The survey of more than 2,800 hospital pharmacy directors was conducted by the ASHP to assess the effect of the flu vaccine shortage on hospitals and patients. The survey report is available online at: http://www.ashp.org/emplibrary/Flu%20Vaccine%20Survey%20Report.pdf.
The survey found that more than 55 percent of respondents report opportunistic vendors offering to sell flu vaccine at highly inflated prices have contacted them. Of these, more than 80 percent report being offered the vaccine at more than four times the original market value, and nearly 20 percent have been offered the vaccine at $800 or more per 10-dose vial (more than 10 times the original market value).
According to the ASHP, the national average cost for a 10-dose vial is approximately $80-100. The average national vaccination cost to consumers is $10-15.
Source: South Carolina Attorney Generals Office
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.